D-factor/leukaemia inhibitory factor: evidence for its role as a mediator in acute and chronic inflammatory disease.
Alexander
H R
HR
Surgical Metabolism Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Billingsley
K G
KG
Block
M I
MI
Fraker
D L
DL
D000208:Acute Disease; D000818:Animals; D002100:Cachexia / Q000503:physiopathology; D002908:Chronic Disease; D004194:Disease; D015870:Gene Expression / Q000187:drug effects; D006131:Growth Inhibitors / Q000494:pharmacology* / Q000502:physiology* / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D053680:Leukemia Inhibitory Factor Receptor alpha Subunit; D008071:Lipoprotein Lipase / Q000096:biosynthesis; D008222:Lymphokines / Q000494:pharmacology* / Q000502:physiology* / Q000627:therapeutic use; D008954:Models, Biological; D018121:Receptors, Cytokine / Q000502:physiology; D053606:Receptors, OSM-LIF
D006131:Growth Inhibitors; D015850:Interleukin-6; C507837:LIF protein, human; C507840:LIFR protein, human; D053605:Leukemia Inhibitory Factor; D053680:Leukemia Inhibitory Factor Receptor alpha Subunit; D008222:Lymphokines; D018121:Receptors, Cytokine; D053606:Receptors, OSM-LIF; D008071:Lipoprotein Lipase